AZN vs DOMO · P/E 28, $288.38B cap vs rev $318.9M
AstraZeneca PLC (AZN) versus Domo Inc (DOMO) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Domo Inc (DOMO) is a software - application company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported DOMO revenue for 2026-01-31 was $318.9M. Net income was -$59.3M. Revenue was up 0.6% from 2025-01-31 to 2026-01-31. DOMO currently screens at market cap $559.7M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. DOMO currently screens at market cap $559.7M.
Not investment advice. Open the AZN and DOMO stock pages for the full models.
Not investment advice.